Literature DB >> 3580649

An investigation of residual psychotic symptoms in discharged schizophrenic patients.

N Tarrier.   

Abstract

Twenty-five patients who had been discharged back into the community after an acute schizophrenic episode but who still experienced residual psychotic symptoms were interviewed to elicit the antecedents, consequences and coping strategies of their symptoms. Fifty-two per cent were able to identify antecedent stimuli and 92 per cent still experienced negative consequences, mainly anxiety. Seventy-two per cent were able to specify coping strategies. Cognitive and behavioural strategies were most frequently cited. However 28 per cent of patients reported that their strategies were of little or no effect and 25 per cent of all strategies were reported ineffective. Patients using multiple strategies were more successful at coping.

Entities:  

Mesh:

Year:  1987        PMID: 3580649     DOI: 10.1111/j.2044-8260.1987.tb00740.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  9 in total

1.  Comparison of children with autism spectrum disorder with and without schizophrenia spectrum traits: gender, season of birth, and mental health risk factors.

Authors:  Kenneth D Gadow; Carla J DeVincent
Journal:  J Autism Dev Disord       Date:  2012-11

Review 2.  Distraction techniques for schizophrenia.

Authors:  C J Crawford-Walker; A King; S Chan
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

3.  A trial of two cognitive behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients. II. Treatment-specific changes in coping and problem-solving skills.

Authors:  N Tarrier; L Sharpe; R Beckett; S Harwood; A Baker; L Yusopoff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-02       Impact factor: 4.328

4.  Smartphone-based ecological momentary assessment and intervention in a blended coping-focused therapy for distressing voices: Development and case illustration.

Authors:  Imogen H Bell; Sarah F Fielding-Smith; Mark Hayward; Susan L Rossell; Michelle H Lim; John Farhall; Neil Thomas
Journal:  Internet Interv       Date:  2018-11-18

5.  Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis.

Authors:  Daniela Polese; Michele Fornaro; Mario Palermo; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Front Psychiatry       Date:  2019-04-17       Impact factor: 4.157

6.  Executive function does not predict coping with symptoms in stable patients with a diagnosis of schizophrenia.

Authors:  Maarten Bak; Lydia Krabbendam; Philippe Delespaul; Karola Huistra; Wil Walraven; Jim van Os
Journal:  BMC Psychiatry       Date:  2008-05-29       Impact factor: 3.630

7.  A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.

Authors:  Max Tsai; Lambros Chrones; Jinhui Xie; Hakop Gevorkyan; Thomas A Macek
Journal:  Psychopharmacology (Berl)       Date:  2016-08-30       Impact factor: 4.530

8.  Smartphone-based ecological momentary assessment and intervention in a coping-focused intervention for hearing voices (SAVVy): study protocol for a pilot randomised controlled trial.

Authors:  Imogen H Bell; Sarah F Fielding-Smith; Mark Hayward; Susan L Rossell; Michelle H Lim; John Farhall; Neil Thomas
Journal:  Trials       Date:  2018-05-02       Impact factor: 2.279

9.  Involuntary Autobiographical Memories in Schizophrenia: Characteristics and Conditions of Elicitation.

Authors:  Mélissa C Allé; Fabrice Berna; Jean-Marie Danion; Dorthe Berntsen
Journal:  Front Psychiatry       Date:  2020-10-09       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.